Cargando…

The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study

BACKGROUND: HTLV-I infected patients often complain of urinary symptomatology. Epidemiological studies have suggested that these individuals have a higher prevalence and incidence of urinary tract infection (UTI) than seronegative controls. However, the diagnosis of UTI in these studies relied only...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Paulo N, Rehem, Ana Paula, Santana, Juliana F, Castro, Neviton, Muniz, Andre L, Salgado, Katia, Rocha, Heonir, Carvalho, Edgar M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828158/
https://www.ncbi.nlm.nih.gov/pubmed/17352816
http://dx.doi.org/10.1186/1471-2334-7-15
_version_ 1782132725147238400
author Rocha, Paulo N
Rehem, Ana Paula
Santana, Juliana F
Castro, Neviton
Muniz, Andre L
Salgado, Katia
Rocha, Heonir
Carvalho, Edgar M
author_facet Rocha, Paulo N
Rehem, Ana Paula
Santana, Juliana F
Castro, Neviton
Muniz, Andre L
Salgado, Katia
Rocha, Heonir
Carvalho, Edgar M
author_sort Rocha, Paulo N
collection PubMed
description BACKGROUND: HTLV-I infected patients often complain of urinary symptomatology. Epidemiological studies have suggested that these individuals have a higher prevalence and incidence of urinary tract infection (UTI) than seronegative controls. However, the diagnosis of UTI in these studies relied only on patient information and did not require confirmation by urine culture. The purpose of this study was to investigate the role of urinary tract infection (UTI) as the cause of urinary symptoms in HTLV-I infected patients. METHODS: In this cross sectional study we interviewed, and cultured urine from, 157 HTLV-I seropositive individuals followed regularly at a specialized clinic. All patients were evaluated by a neurologist and classified according to the Expanded Disability Status Scale (EDSS). Urodynamic studies were performed at the discretion of the treating physician. RESULTS: Sixty-four patients complained of at least one active urinary symptom but UTI was confirmed by a positive urine culture in only 12 of these patients (19%); the majority of symptomatic patients (81%) had negative urine cultures. To investigate the mechanism behind the urinary complaints in symptomatic individuals with negative urine cultures, we reviewed the results of urodynamic studies performed in 21 of these patients. Most of them (90.5%) had abnormal findings. The predominant abnormalities were detrusor sphincter hyperreflexia and dyssynergia, findings consistent with HTLV-I-induced neurogenic bladder. On a multivariate logistic regression, an abnormal EDSS score was the strongest predictor of urinary symptomatology (OR 9.87, 95% CI 3.465 to 28.116, P < 0.0001). CONCLUSION: Urinary symptomatology suggestive of UTI is highly prevalent among HTLV-I seropositive individuals but true UTI is responsible for the minority of cases. We posit that the main cause of urinary symptoms in this population is neurogenic bladder. Our data imply that HLTV-I infected patients with urinary symptomatology should not be empirically treated for UTI but rather undergo urine culture; if a UTI is excluded, further investigation with urodynamic studies should be considered.
format Text
id pubmed-1828158
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18281582007-03-17 The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study Rocha, Paulo N Rehem, Ana Paula Santana, Juliana F Castro, Neviton Muniz, Andre L Salgado, Katia Rocha, Heonir Carvalho, Edgar M BMC Infect Dis Research Article BACKGROUND: HTLV-I infected patients often complain of urinary symptomatology. Epidemiological studies have suggested that these individuals have a higher prevalence and incidence of urinary tract infection (UTI) than seronegative controls. However, the diagnosis of UTI in these studies relied only on patient information and did not require confirmation by urine culture. The purpose of this study was to investigate the role of urinary tract infection (UTI) as the cause of urinary symptoms in HTLV-I infected patients. METHODS: In this cross sectional study we interviewed, and cultured urine from, 157 HTLV-I seropositive individuals followed regularly at a specialized clinic. All patients were evaluated by a neurologist and classified according to the Expanded Disability Status Scale (EDSS). Urodynamic studies were performed at the discretion of the treating physician. RESULTS: Sixty-four patients complained of at least one active urinary symptom but UTI was confirmed by a positive urine culture in only 12 of these patients (19%); the majority of symptomatic patients (81%) had negative urine cultures. To investigate the mechanism behind the urinary complaints in symptomatic individuals with negative urine cultures, we reviewed the results of urodynamic studies performed in 21 of these patients. Most of them (90.5%) had abnormal findings. The predominant abnormalities were detrusor sphincter hyperreflexia and dyssynergia, findings consistent with HTLV-I-induced neurogenic bladder. On a multivariate logistic regression, an abnormal EDSS score was the strongest predictor of urinary symptomatology (OR 9.87, 95% CI 3.465 to 28.116, P < 0.0001). CONCLUSION: Urinary symptomatology suggestive of UTI is highly prevalent among HTLV-I seropositive individuals but true UTI is responsible for the minority of cases. We posit that the main cause of urinary symptoms in this population is neurogenic bladder. Our data imply that HLTV-I infected patients with urinary symptomatology should not be empirically treated for UTI but rather undergo urine culture; if a UTI is excluded, further investigation with urodynamic studies should be considered. BioMed Central 2007-03-12 /pmc/articles/PMC1828158/ /pubmed/17352816 http://dx.doi.org/10.1186/1471-2334-7-15 Text en Copyright © 2007 Rocha et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rocha, Paulo N
Rehem, Ana Paula
Santana, Juliana F
Castro, Neviton
Muniz, Andre L
Salgado, Katia
Rocha, Heonir
Carvalho, Edgar M
The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
title The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
title_full The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
title_fullStr The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
title_full_unstemmed The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
title_short The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
title_sort cause of urinary symptoms among human t lymphotropic virus type i (hltv-i) infected patients: a cross sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828158/
https://www.ncbi.nlm.nih.gov/pubmed/17352816
http://dx.doi.org/10.1186/1471-2334-7-15
work_keys_str_mv AT rochapaulon thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT rehemanapaula thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT santanajulianaf thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT castroneviton thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT munizandrel thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT salgadokatia thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT rochaheonir thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT carvalhoedgarm thecauseofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT rochapaulon causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT rehemanapaula causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT santanajulianaf causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT castroneviton causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT munizandrel causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT salgadokatia causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT rochaheonir causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy
AT carvalhoedgarm causeofurinarysymptomsamonghumantlymphotropicvirustypeihltviinfectedpatientsacrosssectionalstudy